We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
26
DELISTED
Twitter, Inc.
TWTR
$7.61M 0.73%
951,172
+901,063
+1,798% +$36.7M
MRNA icon
27
Moderna
MRNA
$23.9B
$7.42M 0.71%
33,302
+16,300
+96% +$2.47M
ODP
28
DELISTED
ODP
ODP
$7.37M 0.71%
209,681
BNT
29
Brookfield Wealth Solutions
BNT
$12.2B
$6.94M 0.66%
254,594
+16,875
+7% +$541K
ALPAU
30
DELISTED
Alpha Healthcare Acquisition Corp III Units
ALPAU
$6.85M 0.65%
700,000
SWCH
31
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6.52M 0.62%
193,500
+7,400
+4% +$251K
HTZWW
32
Hertz Global Holdings Warrants
HTZWW
$89.4M
$5.44M 0.52%
611,118
+67,049
+12% +$724K
TGT icon
33
Target
TGT
$69B
$4.99M 0.48%
+54,094
New +$8.66M
C icon
34
Citigroup
C
$227B
$4.4M 0.42%
204,944
+132,756
+184% +$6.56M
MSOS icon
35
AdvisorShares Pure US Cannabis ETF
MSOS
$884M
$4.08M 0.39%
1,110,444
+1,100,444
+11,004% +$12.7M
SILJ icon
36
Amplify Junior Silver Miners ETF
SILJ
$3.95B
$3.9M 0.37%
427,624
+138,653
+48% +$1.28M
IMUX icon
37
Immunic
IMUX
$192M
$3.79M 0.36%
120,069
XGN icon
38
Exagen
XGN
$161M
$3.6M 0.34%
1,329,383
-26,031
-2% -$145K
BWAY
39
Brainsway
BWAY
$615M
$3.36M 0.32%
1,833,818
NLSN
40
DELISTED
Nielsen Holdings plc
NLSN
$3.17M 0.3%
+114,400
New +$2.98M
OYST
41
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$2.87M 0.27%
509,794
BREZ
42
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$2.59M 0.25%
250,000
+50,000
+25% +$517K
TRCA
43
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
$2.48M 0.24%
+250,000
New +$2.46M
IBER
44
DELISTED
Ibere Pharmaceuticals
IBER
$2.44M 0.23%
+246,290
New +$2.43M
BENE
45
DELISTED
Benessere Capital Acquisition Corp. Class A Common Stock
BENE
$2.43M 0.23%
233,965
-266,035
-53% -$2.76M
SRLP
46
DELISTED
SPRAGUE RESOURCES LP
SRLP
$2.29M 0.22%
115,486
+99,248
+611% +$1.92M
CONXU
47
DELISTED
CONX Corp. Unit
CONXU
$2.29M 0.22%
+228,480
New +$2.28M
FIP icon
48
FTAI Infrastructure
FIP
$508M
$2.18M 0.21%
+906,949
New +$2.59M
SPKB
49
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$2.06M 0.2%
+208,021
New +$2.05M
ALTU
50
DELISTED
Altitude Acquisition Corp
ALTU
$2.01M 0.19%
+200,000
New +$1.99M

Similar funds

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.